No results for ‘’
Sun Pharmaceutical Industries Ltd
₹1792.50
(0.34%)
Tue, 16 Jun 2026, 09:19 am
Health Technology
Pharmaceuticals: Major
24.5KSun Pharmaceutical Industries Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 31.28 | 27.10 | 17.15 | 12.67 | 27.45 | 25.25 | 22.16 | 28.41 | 37.72 | 54.09 | 43.36 | 23.71 | 56.72 | 43.14 | 22.45 | 49.38 | 67.07 | 27.84 | 40.60 | 38.10 |
| Price to book ratio | 10.13 | 7.36 | 5.11 | 3.27 | 4.73 | 4.82 | 4.82 | 5.65 | 6.41 | 8.26 | 5.98 | 4.50 | 3.10 | 2.78 | 1.87 | 3.09 | 4.57 | 4.21 | 6.11 | 5.77 |
| Price to sales ratio | 11.24 | 10.20 | 7.75 | 5.51 | 9.73 | 8 | 7.37 | 7.54 | 7.42 | 9.01 | 7.02 | 5.28 | 4.50 | 3.96 | 2.57 | 4.28 | 5.68 | 5.37 | 8.12 | 7.98 |
| Price to cash flow ratio | 69.54 | 65.55 | 41.69 | 10.24 | 39.78 | 18.77 | 25.49 | 24.16 | 28.72 | 45.90 | 29.13 | 23.19 | 29.88 | 47.08 | 12.66 | 22.99 | 24.06 | 44.42 | 30.79 | 28.29 |
| Enterprise value | 18303Cr | 21029Cr | 24498Cr | 21746Cr | 35141Cr | 44832Cr | 55467Cr | 81203Cr | 114000Cr | 245000Cr | 196000Cr | 163000Cr | 119000Cr | 118000Cr | 85295Cr | 141000Cr | 211000Cr | 231000Cr | 376000Cr | 393000Cr |
| Enterprise value to EBITDA ratio | 37.35 | 31.33 | 15.87 | 11.66 | 29.72 | 22.74 | 17 | 16.52 | 15.43 | 30.29 | 22.91 | 16.76 | 21.23 | 17.62 | 11.70 | 16.40 | 20.56 | 19.84 | 31.03 | 26.16 |
| Debt to equity ratio | 1.18 | 0.40 | 0.03 | 0.03 | 0.02 | 0.04 | 0.03 | 0.02 | 0.14 | 0.35 | 0.26 | 0.27 | 0.27 | 0.25 | 0.18 | 0.08 | 0.03 | 0.12 | 0.05 | 0.03 |
| Return on equity % | 42.14 | 35.95 | 38.30 | 30.20 | 18.17 | 20.98 | 24.47 | 21.96 | 18.76 | 20.56 | 15.51 | 20.47 | 5.59 | 6.70 | 8.69 | 6.33 | 6.93 | 16.29 | 16.01 | 16.09 |
Sun Pharmaceutical Industries Ltd Enterprise Value
The Sun Pharmaceutical Industries Ltd Enterprise Value is a key financial metric used by investors to evaluate Sun Pharmaceutical Industries Ltd's valuation, profitability, and overall financial performance. Tracking the Sun Pharmaceutical Industries Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Sun Pharmaceutical Industries Ltd (NSE: SUNPHARMA, BSE: 524715) is currently trading at ₹1792.50, with a market capitalization of ₹426927.63Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Sun Pharmaceutical Industries Ltd Enterprise Value is essential for fundamental analysis.
Sun Pharmaceutical Industries Ltd Enterprise Value Current Value
The current Sun Pharmaceutical Industries Ltd Enterprise Value stands at 393000Cr.
The latest Sun Pharmaceutical Industries Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Sun Pharmaceutical Industries Ltd Enterprise Value Historical Trend
The Sun Pharmaceutical Industries Ltd Enterprise Value has shown the following historical trend:
- 2024: 393000Cr
- 2023: 376000Cr
- 2022: 231000Cr
- 2021: 211000Cr
- 2020: 141000Cr
The recent rise in Sun Pharmaceutical Industries Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Sun Pharmaceutical Industries Ltd Enterprise Value Indicates for Investors
The Sun Pharmaceutical Industries Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd Enterprise Value Analysis Summary
The Sun Pharmaceutical Industries Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Sun Pharmaceutical Industries Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Sun Pharmaceutical Industries Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.